System performance and Evidence Base
The report notes that the Sensium system acts as a clinical early warning system for acute care; the System detects and notifies nurses and physicians on several, helping prevent the advent of hospital-based adverse events, the cost of which currently amounts to GBP 2.5 billion per year. Sensium differentiates itself from competitors due to the product’s robust evidence base and real-word deployments.
Hospital @ Home service
The report noted the development of a Hospital@ Home solution, which will help hospitals reach beyond traditional infrastructure by providing oversight of managed home care providers, enabling additional capacity. The model is expected to yield significant growth to the company in the future.
Commercial model and cost savings
Frost & Sullivan notes that the Sensium System’s ability to support early detection of any deterioration coupled with an outcome-centric approach leads to additional hospital capacity. Sensium leverages a technology-enabled care delivery model to decrease the cost of care to patients, payers, and providers. The company’s innovative Sensium solution cost-effectively optimizes patient outcomes by supporting early intervention. The Surgical Company – Connected Care’s commercial model can be customized based on targets set by the hospitals. Recently the company has taken the route of value-based contracting by identifying and enabling providers’ pain points through its product use. Remunerations are tied to hospital performance.